Ryan J. Hartmaier
- Pulmonary and Respiratory Medicine top 2%
- Oncology top 5%
- Molecular Biology top 10%
- Cancer Research top 2%
- Endocrinology, Diabetes and Metabolism top 5%
- Co-authors
- Juliann ChmieleckiJeffrey S. RossSteffi OesterreichEthan SokolLaurie M. GayNikita PozdeyevDaniel W. BowlesLauren Fishbein
- Topics
- Lung Cancer Treatments and Mutations (36 papers)Cancer Genomics and Diagnostics (26 papers)Colorectal Cancer Treatments and Studies (13 papers)
- Partner nations
- United StatesUnited KingdomSouth Korea
In The Last Decade
Ryan J. Hartmaier
60 papers receiving 2.1k citations
Hit Papers
Peers
Comparison fields: 5 of 92
- Pulmonary and Respiratory Medicine 948
- Oncology 936
- Molecular Biology 878
- Cancer Research 687
- Endocrinology, Diabetes and Metabolism 319
Countries citing papers authored by Ryan J. Hartmaier
This map shows the geographic impact of Ryan J. Hartmaier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryan J. Hartmaier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryan J. Hartmaier more than expected).
Fields of papers citing papers by Ryan J. Hartmaier
This network shows the impact of papers produced by Ryan J. Hartmaier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryan J. Hartmaier. The network helps show where Ryan J. Hartmaier may publish in the future.
Co-authorship network of co-authors of Ryan J. Hartmaier
This figure shows the co-authorship network connecting the top 25 collaborators of Ryan J. Hartmaier. A scholar is included among the top collaborators of Ryan J. Hartmaier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryan J. Hartmaier. Ryan J. Hartmaier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 15 | |
| 3 | 12 | |
| 4 | Candidate mechanisms of acquired resistance to first-line osimertinib in EGFR-mutated advanced non-small cell lung cancerbreakdown → | 130 |
| 5 | Analysis of acquired resistance mechanisms to osimertinib in patients with EGFR-mutated advanced non-small cell lung cancer from the AURA3 trialbreakdown → | 95 |
| 6 | Osimertinib + Savolitinib to Overcome Acquired MET-Mediated Resistance in Epidermal Growth Factor Receptor–Mutated, MET -Amplified Non–Small Cell Lung Cancer: TATTONbreakdown → | 95 |
| 7 | 10 | |
| 8 | 43 | |
| 9 | 41 | |
| 10 | 22 | |
| 11 | Genetic Analysis of 779 Advanced Differentiated and Anaplastic Thyroid Cancersbreakdown → | 374 |
| 12 | 24 | |
| 13 | 85 | |
| 14 | 23 | |
| 15 | 19 | |
| 16 | 42 | |
| 17 | 1 | |
| 18 | 118 | |
| 19 | 31 | |
| 20 | 42 |
About Ryan J. Hartmaier
Ryan J. Hartmaier is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Oncology, having authored 63 papers that have together received 2.1k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (36 papers), Cancer Genomics and Diagnostics (26 papers) and Colorectal Cancer Treatments and Studies (13 papers). The work is most often cited by research in Cancer Research (687 citations), Oncology (936 citations) and Pulmonary and Respiratory Medicine (948 citations). Ryan J. Hartmaier has collaborated with scholars based in United States, United Kingdom and South Korea. Frequent co-authors include Juliann Chmielecki, Jeffrey S. Ross, Steffi Oesterreich, Ethan Sokol, Laurie M. Gay, Nikita Pozdeyev, Daniel W. Bowles, Lauren Fishbein, Stephanie Davis and Aik Choon Tan. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.